Clinical Trial Update: Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating maintenance olaparib in platinum-sensitive advanced non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: TERMINATED